Tamsulosin Versus Nifedipine To Facilitate Urinary Stone Passage: A Systematic Review And Meta-Analysis

Yongqiang Zhang,Dongbo Yuan,Haofu Rao,Tianfei Cheng,Boshi Luan,Wei Wang,Jiaming Su,Yuanlin Wang,Zhaolin Sun,Guiping Ouyang,Jianguo Zhu
2018-01-01
Abstract:Objectives: To assess the effectiveness of Tamsulosin versus Nifedipine, as an expulsive agent, for both intact ureteral stones and stones after shock wave lithotripsy. Methods: Relevant studies were searched for in MEDLINE, SCOPUS, and the Cochrane database libraries. All randomized controlled trials comparing Tamsulosin to Nifedipine for the treatment of ureteral stones (intact or after shock wave lithotripsy), were included in the study. The primary outcome was the proportion of the patients who passed the stones. Results: Ten randomized trials (RCT), with a total of 4816 patients that underwent medical therapy only, were included in this meta-analysis. Tamsulosin was associated with a higher risk of stone passage rate (SPR) (OR = 2.67, 95% CI 1.31-5.44, P<0.05), and with a shorter average stone-expulsion time, in tamsulosin groups (WMD: -1.95; 95% CI: -3.73-0.17; P = 0.03). There were no statistically significant differences in the side effects between these groups (OR = 0.78, 95% CI 0.60-1.02, P = 0.07). Three trials comprised of 199 patients who had the expulsive therapy after shock wave lithotripsy. No statistically significant differences were detected in the SPR, between the two groups (OR = 1.56, 95% CI 0.82-2.96, P = 0.17). Conclusions: This meta-analysis suggested that Tamsulosin was more effective and quicker than Nifedipine as an expulsive agent for the intact ureteral stones.
What problem does this paper attempt to address?